Foley Partner Ric Henschel was quoted in an article that appeared on IP Law360 on April 6, 2009 titled “Fed Circ. Rejects Amgen Bid For DNA Patent.” Henschel provides insight into a federal appeals court decision to uphold the U.S. Patent and Trademark Office’s rejection of a DNA patent application filed by Amgen Inc., adding that the ruling was neither a clear nor satisfying outcome for the biotechnology community.
Related News
14 February 2025
In the News
Brian Wheeler Joins Podcast to Discuss Legal Journey
Foley & Lardner LLP partner Brian Wheeler joined the Hsu Untied podcast to discuss his legal career.
14 February 2025
In the News
Pavan Agarwal Featured in Leadership Q&A – 'Reflecting our firm’s core values drives me to do my best'
Foley & Lardner LLP partner Pavan Agarwal is featured by Law.com for his career journey, legal practice, and leadership in the article, “How I Made Practice Group Chair: ‘Keep Listening and Keep Learning,’ Says Pavan Agarwal of Foley & Lardner.”
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."